$SDCH
SideChannel, Inc.

2024 Q2 Form 10-Q Financial Statement

#000149315224018014 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $1.846M $1.927M $1.617M
YoY Change 5.49% 19.17% 646700.0%
Cost Of Revenue $944.0K $1.059M $880.0K
YoY Change 7.76% 20.34%
Gross Profit $902.0K $868.0K $737.0K
YoY Change 3.2% 17.77% 294700.0%
Gross Profit Margin 48.86% 45.04% 45.58%
Selling, General & Admin $915.0K $1.005M $1.427M
YoY Change -22.06% -29.57% 116.41%
% of Gross Profit 101.44% 115.78% 193.62%
Research & Development $141.0K $123.0K $168.0K
YoY Change -21.67% -26.79% 19.22%
% of Gross Profit 15.63% 14.17% 22.8%
Depreciation & Amortization $45.00K
YoY Change 0.0%
% of Gross Profit 6.11%
Operating Expenses $1.056M $1.128M $1.595M
YoY Change -32.65% -29.28% 99.3%
Operating Profit -$154.0K -$260.0K -$858.0K
YoY Change -77.81% -69.7% 7.24%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $8.000K $8.000K $2.000K
YoY Change -46.67% 300.0%
Pretax Income -$146.0K -$252.0K -$856.0K
YoY Change -78.5% -70.56% 6.99%
Income Tax $1.000K
% Of Pretax Income
Net Earnings -$146.0K -$253.0K -$856.0K
YoY Change -78.5% -70.44% 6.99%
Net Earnings / Revenue -7.91% -13.13% -52.94%
Basic Earnings Per Share $0.00 $0.00 -$0.01
Diluted Earnings Per Share $0.00 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 224.4M shares 222.0M shares 148.9M shares
Diluted Shares Outstanding 225.0M shares 222.8M shares 148.9M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $851.0K $1.902M
YoY Change -55.26% -56.67%
Cash & Equivalents $1.105M $851.0K $1.902M
Short-Term Investments
Other Short-Term Assets $626.0K $463.0K
YoY Change 35.21% 43.25%
Inventory
Prepaid Expenses $446.0K $283.0K
Receivables $865.0K $910.0K $896.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.418M $2.387M $3.261M
YoY Change -9.17% -26.8% -30.81%
LONG-TERM ASSETS
Property, Plant & Equipment $36.00K $24.00K
YoY Change 50.0%
Goodwill $1.356M $1.356M $1.356M
YoY Change 0.0% 0.0%
Intangibles $4.940M
YoY Change
Long-Term Investments
YoY Change
Other Assets $60.00K $240.0K
YoY Change -75.0% -42.86%
Total Long-Term Assets $1.407M $1.440M $6.536M
YoY Change -78.4% -77.97% 1456.19%
TOTAL ASSETS
Total Short-Term Assets $2.418M $2.387M $3.261M
Total Long-Term Assets $1.407M $1.440M $6.536M
Total Assets $3.825M $3.827M $9.797M
YoY Change -58.32% -60.94% 90.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $498.0K $765.0K
YoY Change -34.9% 76.39%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $50.00K
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $997.0K $1.062M $1.382M
YoY Change -11.06% -23.15% 218.65%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $997.0K $1.062M $1.382M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $997.0K $1.062M $1.593M
YoY Change -25.15% -33.33% 267.3%
SHAREHOLDERS EQUITY
Retained Earnings -$19.58M -$19.44M -$13.39M
YoY Change 39.19% 45.16%
Common Stock $226.0K $224.0K $150.0K
YoY Change 6.1% 49.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.828M $2.765M $8.204M
YoY Change
Total Liabilities & Shareholders Equity $3.825M $3.827M $9.797M
YoY Change -58.32% -60.94% 90.85%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$146.0K -$253.0K -$856.0K
YoY Change -78.5% -70.44% 6.99%
Depreciation, Depletion And Amortization $45.00K
YoY Change 0.0%
Cash From Operating Activities $32.00K -$651.0K
YoY Change -104.92% -4.48%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 32.00K -651.0K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 0.000 0.000
Net Change In Cash 32.00K -651.0K
YoY Change -104.92% -4.48%
FREE CASH FLOW
Cash From Operating Activities $32.00K -$651.0K
Capital Expenditures $0.00
Free Cash Flow -$651.0K
YoY Change -4.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
usd
CY2023Q3 us-gaap Other Liabilities
OtherLiabilities
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
usd
CY2023Q4 SDCH Stock Issued During Period Value For Warrants
StockIssuedDuringPeriodValueForWarrants
usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
SDCH Stock Based Compensation Included In Accounts Payable And Accrued Liabilities
StockBasedCompensationIncludedInAccountsPayableAndAccruedLiabilities
usd
SDCH Purchase Of Restricted Stock Units Sold By Employees To Pay For Taxes Due On Vested Rsus
PurchaseOfRestrictedStockUnitsSoldByEmployeesToPayForTaxesDueOnVestedRsus
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
SDCH
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
224355805 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
851000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1053000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
910000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
834000 usd
CY2024Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
180000 usd
CY2023Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
180000 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
446000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
381000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
2387000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
2448000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
1356000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
1356000 usd
CY2024Q1 us-gaap Deferred Costs
DeferredCosts
60000 usd
CY2023Q3 us-gaap Deferred Costs
DeferredCosts
150000 usd
CY2024Q1 us-gaap Assets
Assets
3827000 usd
CY2023Q3 us-gaap Assets
Assets
3984000 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
498000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
613000 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
564000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
280000 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
50000 usd
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
11000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1062000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
954000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
1062000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
954000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
224355805 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
224355805 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
213854781 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213854781 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
224000 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
214000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21979000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21755000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19438000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18939000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2765000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3030000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3827000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3984000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3663000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3163000 usd
us-gaap Cost Of Revenue
CostOfRevenue
1950000 usd
us-gaap Cost Of Revenue
CostOfRevenue
1561000 usd
us-gaap Gross Profit
GrossProfit
1713000 usd
us-gaap Gross Profit
GrossProfit
1602000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1558000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2020000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
249000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
303000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
1128000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1595000 usd
us-gaap Operating Expenses
OperatingExpenses
2232000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-260000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-858000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
21000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-252000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-856000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-498000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-253000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-856000 usd
us-gaap Net Income Loss
NetIncomeLoss
-499000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
222773052 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222773052 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148928663 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
148928663 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218653945 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
218653945 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148830224 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
148830224 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3030000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
8000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
81000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-246000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2873000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
12000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
133000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-253000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2765000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
18000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
118000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-602000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8930000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8930000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
13000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
117000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
117000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-856000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
8204000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
8204000 usd
us-gaap Net Income Loss
NetIncomeLoss
-499000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1458000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
96000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
90000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
234000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
245000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
76000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
284000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
65000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-37000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-115000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-11000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
284000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
242000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-152000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1128000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
50000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-50000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-202000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1128000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1053000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3030000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
851000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1902000 usd
SDCH Stock Based Compensation Included In Accounts Payable And Accrued Liabilities
StockBasedCompensationIncludedInAccountsPayableAndAccruedLiabilities
21000 usd
SDCH Shares Issued For Services Non Cash Investing And Financing Activities
SharesIssuedForServicesNonCashInvestingAndFinancingActivities
20000 usd
SDCH Shares Issued For Services Non Cash Investing And Financing Activities
SharesIssuedForServicesNonCashInvestingAndFinancingActivities
31000 usd
SDCH Purchase Of Restricted Stock Units Sold By Employees To Pay For Taxes Due On Vested Rsus
PurchaseOfRestrictedStockUnitsSoldByEmployeesToPayForTaxesDueOnVestedRsus
66000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
2116618 shares
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zdr94SDHTT7f" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_860_zLvYxOuldWB8">Reclassifications</span></span></i></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Certain prior year amounts have been reclassified to be comparable with the current year’s presentation.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p>
CY2024Q1 SDCH Percentage Of Accounts Receivable
PercentageOfAccountsReceivable
0.03 pure
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
10000 usd
SDCH New Accounting Pronouncements Not Yet Adopted
NewAccountingPronouncementsNotYetAdopted
<p id="xdx_84D_ecustom--NewAccountingPronouncementsNotYetAdopted_zd0NBl03gnG5" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_869_zkhM0ReuRQa4">Recently Issued Accounting Standards Not Yet Adopted</span></span></i></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” which provides guidance to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the guidance enhances interim disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss, provides new segment disclosure requirements for entities with a single reportable segment and contains other disclosure requirements. The purpose of the guidance is to enable investors to better understand an entity’s overall performance and assess potential future cash flows. The guidance is effective for fiscal years beginning December 15, 2023, and interim periods within fiscal years beginning December 15, 2024. For us, annual reporting requirements will be effective for our fiscal year 2025 beginning on October 1, 2024 and interim reporting requirements will be effective beginning with our fourth quarter of fiscal year 2025. Early adoption is permitted. We are currently evaluating the impact that the new guidance will have on our consolidated financial statements.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” which updates income tax disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation table and disaggregation of income taxes paid, net of refunds, by jurisdiction. All entities are required to apply the guidance prospectively, with the option to apply it retrospectively. The guidance is effective for fiscal years beginning after December 15, 2024, which for us is our fiscal year 2026 beginning on October 1, 2025. Early adoption is permitted. We are currently evaluating the impact that the new guidance will have on our consolidated financial statements.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The Company does not believe that any recently issued, but not yet effective accounting standards, when adopted, will have a material effect on the accompanying consolidated financial statements.</span></p>
CY2021Q4 us-gaap Area Of Land
AreaOfLand
500 sqft
CY2021Q4 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
option to renew annually for three (3) twelve (12) month periods through December 2025.
CY2021Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
967 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
564000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
280000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
280000 usd
SDCH Contract With Customer Liability Revenue Deferred
ContractWithCustomerLiabilityRevenueDeferred
741000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
457000 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
564000 usd
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
224355805 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213854781 shares
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
437643 shares
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20000 usd
CY2023Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
17415437 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.18
CY2023Q4 SDCH Bid Price
BidPrice
0.36
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
43200000 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
69281000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.39
CY2023 SDCH Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y3M21D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
17415000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.18
SDCH Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Non Options Outstanding Weighted Average Remaining Contractual Terms Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsOutstandingWeightedAverageRemainingContractualTermsGranted
P4Y9M
SDCH Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Tendered
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsTendered
43538000 shares
SDCH Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Outstanding Weighted Average Exercise Price Tendered
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsOutstandingWeightedAverageExercisePriceTendered
0.36
SDCH Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Non Options Outstanding Weighted Average Remaining Contractual Terms Tendered
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsOutstandingWeightedAverageRemainingContractualTermsTendered
P2Y3M
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
43158000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.33
SDCH Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M20D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.05
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.14
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
300000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20000 usd
CY2024Q1 SDCH Amortization Of Outstanding Equity
AmortizationOfOutstandingEquity
280000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
757000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y4M24D
SDCH Purchase Of Rsus Sold By Employees To Pay For Taxes Due On Vested Rsus
PurchaseOfRsusSoldByEmployeesToPayForTaxesDueOnVestedRsus
66000 usd
us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
214000 usd
CY2024Q1 SDCH Amortization Of Outstanding Equity
AmortizationOfOutstandingEquity
280000 usd
SDCH Purchase Of Rsus Sold By Employees To Pay For Taxes Due On Vested Rsus
PurchaseOfRsusSoldByEmployeesToPayForTaxesDueOnVestedRsus
66000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
266000 usd
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
31000 shares
CY2023Q1 SDCH Amortization Of Outstanding Equity
AmortizationOfOutstandingEquity
235000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001493152-24-018014-index-headers.html Edgar Link pending
0001493152-24-018014-index.html Edgar Link pending
0001493152-24-018014.txt Edgar Link pending
0001493152-24-018014-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sdch-20240331.xsd Edgar Link pending
Show.js Edgar Link pending
sdch-20240331_def.xml Edgar Link unprocessable
sdch-20240331_lab.xml Edgar Link unprocessable
sdch-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
sdch-20240331_cal.xml Edgar Link unprocessable